Research quantifies effect of chronic diseases on racial disparity in COVID-associated hospitalizations

by Louisiana State UniversityCredit: CC0 Public DomainLSU Health New Orleans conducted the first research using disease surveillance data to quantify the effect of chronic diseases on racial disp

Updated on: June 28,2024

Research quantifies effect of chronic diseases on racial disparity in COVID-associated hospitalizations

by Louisiana State UniversityCredit: CC0 Public DomainLSU Health New Orleans conducted the first research using disease surveillance data to quantify the effect of chronic diseases on racial disp

Updated on:June 28,2024

New regulator in aggressive breast cancer cells discovered

by Leibniz Institute on AgingThe protein TRPS1 controls the activity of the YAP protein in breast cancer. If YAP activity is downregulated, the survival prognosis for patients is reduced. If TRPS1 is

Updated on: April 22,2024

New regulator in aggressive breast cancer cells discovered

by Leibniz Institute on AgingThe protein TRPS1 controls the activity of the YAP protein in breast cancer. If YAP activity is downregulated, the survival prognosis for patients is reduced. If TRPS1 is

Updated on:April 22,2024

Policies favoring high-volume hospitals may disadvantage rural cancer patients

by University of PittsburghCredit: Pixabay/CC0 Public DomainPatients with cancer who live in rural Pennsylvania counties appear to know that they may have better outcomes if they receive their ca

Updated on: February 03,2024

Policies favoring high-volume hospitals may disadvantage rural cancer patients

by University of PittsburghCredit: Pixabay/CC0 Public DomainPatients with cancer who live in rural Pennsylvania counties appear to know that they may have better outcomes if they receive their ca

Updated on:February 03,2024

The search to discover why 'outliers' survive deadliest cancers

by Isabelle TOURNÉThe biotech start-up Cure51 is working on the first global molecular database of exceptional survivors of cancer.When Herve found out he had glioblastoma—the most aggressive form of

Updated on: March 30,2024

The search to discover why 'outliers' survive deadliest cancers

by Isabelle TOURNÉThe biotech start-up Cure51 is working on the first global molecular database of exceptional survivors of cancer.When Herve found out he had glioblastoma—the most aggressive form of

Updated on:March 30,2024

Drugmaker GSK says EU to review womb cancer treatment

Credit: Unsplash/CC0 Public DomainBritish pharmaceutical giant GSK said on Tuesday that the EU's drug watchdog will study a new treatment for a common type of womb cancer for potential approval in

Updated on: January 30,2024

Drugmaker GSK says EU to review womb cancer treatment

Credit: Unsplash/CC0 Public DomainBritish pharmaceutical giant GSK said on Tuesday that the EU's drug watchdog will study a new treatment for a common type of womb cancer for potential approval in

Updated on:January 30,2024

Researchers test novel gene therapy for glioblastoma

by University Hospitals Cleveland Medical CenterGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0A novel gene therapy clinical trial at University Hospitals Seidman Cancer Center and

Updated on: June 24,2024

Researchers test novel gene therapy for glioblastoma

by University Hospitals Cleveland Medical CenterGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0A novel gene therapy clinical trial at University Hospitals Seidman Cancer Center and

Updated on:June 24,2024

Researchers map genetic signature of precursor to liver cancer

by Curtin UniversityProfessor Nina Tirnitz-Parker and Dr. Rodrigo Carlessi, from Curtin University. Credit: Curtin UniversityResearchers at Curtin University have identified the genetic signature

Updated on: February 24,2024

Researchers map genetic signature of precursor to liver cancer

by Curtin UniversityProfessor Nina Tirnitz-Parker and Dr. Rodrigo Carlessi, from Curtin University. Credit: Curtin UniversityResearchers at Curtin University have identified the genetic signature

Updated on:February 24,2024

Skin cancer-related mutations higher in the UK than Singapore, new study shows

by Wellcome Trust Sanger InstituteA representation of protein-altering mutations in 1 square centimeter of skin from donors of the UK and Singapore. The UK square contains many more circles. Cred

Updated on: February 23,2024

Skin cancer-related mutations higher in the UK than Singapore, new study shows

by Wellcome Trust Sanger InstituteA representation of protein-altering mutations in 1 square centimeter of skin from donors of the UK and Singapore. The UK square contains many more circles. Cred

Updated on:February 23,2024

Long-term cardiomyopathy risk varies by chemo agent

(HealthDay)—Long-term cardiomyopathy risk varies by chemotherapy agent for childhood cancer survivors, with a decreased risk for daunorubicin versus doxorubicin, according to a study recently publishe

Updated on: April 18,2024

Long-term cardiomyopathy risk varies by chemo agent

(HealthDay)—Long-term cardiomyopathy risk varies by chemotherapy agent for childhood cancer survivors, with a decreased risk for daunorubicin versus doxorubicin, according to a study recently publishe

Updated on:April 18,2024

Researchers uncover potential biomarkers of positive response to immunotherapy

by Denise Heady,University of California, Los AngelesResponse to ICI or MAPKi therapy is associated with increased T cell infiltration and enhanced interferon gamma (IFNγ) pathway activity in th

Updated on: January 30,2024

Researchers uncover potential biomarkers of positive response to immunotherapy

by Denise Heady,University of California, Los AngelesResponse to ICI or MAPKi therapy is associated with increased T cell infiltration and enhanced interferon gamma (IFNγ) pathway activity in th

Updated on:January 30,2024

Researchers develop antibodies that alleviate 'cancer cachexia' in patients

by Daegu Gyeongbuk Institute of Science and TechnologyCredit: Daegu Gyeongbuk Institute of Science and TechnologyA DGIST research team led by Professor Kyungmoo Yea of the Department of New Biology de

Updated on: February 01,2024

Researchers develop antibodies that alleviate 'cancer cachexia' in patients

by Daegu Gyeongbuk Institute of Science and TechnologyCredit: Daegu Gyeongbuk Institute of Science and TechnologyA DGIST research team led by Professor Kyungmoo Yea of the Department of New Biology de

Updated on:February 01,2024

New tumor-selective light treatment could kill breast cancer cells with greater accuracy and improve tumor control

byNational University of SingaporeGraphical abstract. Credit:ACS Nano(2023). DOI: 10.1021/acsnano.3c01916Breast cancer is the most common cancer affecting women in Singapore. Treatme

Updated on: January 13,2024

New tumor-selective light treatment could kill breast cancer cells with greater accuracy and improve tumor control

byNational University of SingaporeGraphical abstract. Credit:ACS Nano(2023). DOI: 10.1021/acsnano.3c01916Breast cancer is the most common cancer affecting women in Singapore. Treatme

Updated on:January 13,2024